(Q40474405)

20 September 2017

1 reference

title

Diagnosis and management of insulin resistance in dogs and cats with diabetes mellitus. (English)

1 reference

20 September 2017

1 reference

Peterson ME

1

1 reference

20 September 2017

1 May 1995

1 reference

Veterinary Clinics of North America: Small Animal Practice

20 September 2017

1 reference

20 September 2017

25

1 reference

20 September 2017

3

1 reference

20 September 2017

691-713

1 reference

Influence of thyroid hormone level on insulin action in human adipose tissue

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Lipoprotein-induced insulin resistance in aortic endothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Diminished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Insulin action in human adipose tissue in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Steroid diabetes in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Growth Hormone-induced Diabetes and High Levels of Serum Insulin in Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Impact of obesity on insulin action in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Acidemia and Insulin Resistance in the Diabetic Ketoacidotic Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Acromegaly in the Dog

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Diabetes mellitus associated with other endocrine disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Brittle diabetes--present concepts.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Characterization of cat insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Impairment of glucose tolerance in hyperthyroid cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Glucose tolerance and insulin secretion in spontaneously hyperthyroid cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Observations in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Functional pituitary acidophil adenoma in a cat with diabetes mellitus and acromegalic features

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

A review of new developments in type 2 diabetes in human beings and cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Insulin resistance--mechanisms, syndromes, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

The Immunogenicity of Different Insulins in Several Animal Species

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Insulin Resistance Caused by Massive Degradation of Subcutaneous Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Effects of megestrol acetate on glucose tolerance and growth hormone secretion in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Hyperadrenocorticism.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Acromegaly in 14 cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Studies on the effect of thyroxine replacement therapy on the increased insulin response to hyperglycemia in the thyroidectomized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Progestin-induced growth hormone excess in the dog originates in the mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Absorption kinetics of regular, isophane, and protamine zinc insulin in normal cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

Massive insulin resistance apparently due to rapid clearance of circulating insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2895%2950063-4

7 January 2021

10.1016/S0195-5616(95)50063-4

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7660542